Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017 May;46(5):699-704.

Prevalence and Incidence of Multiple Sclerosis in Tehran, Iran

Affiliations

Prevalence and Incidence of Multiple Sclerosis in Tehran, Iran

Sharareh Eskandarieh et al. Iran J Public Health. 2017 May.

Abstract

Background: Tehran is the capital of Iran with an increasing Multiple Sclerosis (MS) incidence. A retrospective population-based study was conducted to evaluate the status of MS prevalence and MS incidence trends in Tehran Province, Iran.

Methods: A population-based study was conducted from 1991 to 2014 in Tehran Province, the capital city of Iran based on Iranian MS Society (IMSS) registry system. A structured questionnaire design to cover the important epidemiological variables, related at the individual level for MS. A Monte Carlo Permutation method was utilized to test whether the apparent change in MS trends during 1991-2014 was statistically significant.

Results: MS incidence was significantly increased during our study period. The annual percent change (APC) was 12.8% in women during 1991 to 2004 and 12.5% in men during the same period. The point prevalence of MS was 101.39 per 100000 populations in 2014. The age-adjusted prevalence rates were 134.03 and for male patients were 42.45 per 100000.

Conclusion: MS prevalence and incidence in Tehran are markedly rising, it is crucial to elucidate the causes of the increasing trends and implement efficient policies lowering disease burden.

Keywords: Incidence; Joinpoint regression; Multiple sclerosis; Prevalence.

PubMed Disclaimer

Figures

Fig. 1:
Fig. 1:
MS incidence via Join point regression analysis in various sex groups

References

    1. Koch-Henriksen N, Sørensen P. (2010). The changing demographic pattern of multiple sclerosis epidemiology. Lancet Neurol, 9:520–32. - PubMed
    1. Melcon M, Correale J, Melcon C. (2014). Is it time for a new global classification of multiple sclerosis? J Neurol Sci, 344(1–2):171–81. - PubMed
    1. Dua T, Romani P. (2008). Atlas of Multiple Sclerosis Resources in the World, WHO, Geneva.
    1. Heydarpour P, Khoshkish S, Abtahi S, Moradi-Lakeh M, Sahraian MA. (2015). Multiple Sclerosis Epidemiology in Middle East and North Africa: A Systematic Review and Meta-Analysis. Neuroepidemiology, 44(4):232–244. - PubMed
    1. Etemadifar M, Izadi S, Nikseresht A, Sharifian M, Sahraian M, Nasr Z. (2014). Estimated Prevalence and Incidence of Multiple Sclerosis in Iran. Eur Neurol 72:370–74. - PubMed

LinkOut - more resources